Loading
A phase 2 trial of IBI343, gemcitabine and nab-paclitaxel in pancreatic cancer, run by Zhejiang University, now recruiting.
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer is a phase 2, randomised interventional study registered as NCT06770439 by Zhejiang University, with a registry enrolment figure of 64 participants, started 2025-04-18 and due to reach its primary completion in 2027-01. Interventions recorded: IBI343; Gemcitabine+Albumin-bound paclitaxel. Conditions listed: Advanced Pancreatic Cancers. Primary outcome: Objective Response Rate; Adverse Event. Pancreatic eligibility wording from the registry: "* Histopathologically confirmed unresectable locally advanced, recurrent, or metastatic pancreatic adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.